Home » Topics » BioWorld Science

BioWorld Science
RSS

AAV9-cTuberin extends survival and reduces brain pathology in vivo

Jan. 14, 2021

Alexion pauses enrollment in phase III study of Ultomiris for severe COVID-19

Jan. 14, 2021

Urinary neopterin is a new biomarker of ALS

Jan. 14, 2021

OLT-1177 rescues cognitive impairment in a mouse model of AD

Jan. 14, 2021

Interim analysis data from phase IIb study of iDose TR sustained-release travoprost implant

Jan. 14, 2021

'Unconventional' gamma-delta T cells recognize malaria-infected RBCs

Jan. 14, 2021

Arcutis initiates pivotal phase III studies of roflumilast cream in patients with atopic dermatitis

Jan. 14, 2021

Eisai presents new EphA4-targeting antibodies for AD

Jan. 14, 2021

DNA base composition determines oncogene function

Jan. 14, 2021

Fochon Pharmaceuticals synthesizes new URAT1 inhibitors

Jan. 14, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026